MA53280A - Composés utiles dans la thérapie du vih - Google Patents

Composés utiles dans la thérapie du vih

Info

Publication number
MA53280A
MA53280A MA053280A MA53280A MA53280A MA 53280 A MA53280 A MA 53280A MA 053280 A MA053280 A MA 053280A MA 53280 A MA53280 A MA 53280A MA 53280 A MA53280 A MA 53280A
Authority
MA
Morocco
Prior art keywords
useful compounds
hiv therapy
hiv
therapy
compounds
Prior art date
Application number
MA053280A
Other languages
English (en)
Inventor
La Rosa Martha Alicia De
John Franklin Miller
B Narasimhulu Naidu
Lita Suwandi
David Temelkoff
Emile Johann Velthuisen
Original Assignee
Glaxosmithkline Ip No 2 Ltd
Viiv Healthcare Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Glaxosmithkline Ip No 2 Ltd, Viiv Healthcare Co filed Critical Glaxosmithkline Ip No 2 Ltd
Publication of MA53280A publication Critical patent/MA53280A/fr

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H19/00—Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical; Nucleosides; Mononucleotides; Anhydro-derivatives thereof
    • C07H19/02—Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical; Nucleosides; Mononucleotides; Anhydro-derivatives thereof sharing nitrogen
    • C07H19/04—Heterocyclic radicals containing only nitrogen atoms as ring hetero atom
    • C07H19/16—Purine radicals
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D473/00—Heterocyclic compounds containing purine ring systems
    • C07D473/26—Heterocyclic compounds containing purine ring systems with an oxygen, sulphur, or nitrogen atom directly attached in position 2 or 6, but not in both
    • C07D473/32—Nitrogen atom
    • C07D473/34—Nitrogen atom attached in position 6, e.g. adenine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/7042—Compounds having saccharide radicals and heterocyclic rings
    • A61K31/7052—Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides
    • A61K31/706—Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides containing six-membered rings with nitrogen as a ring hetero atom
    • A61K31/7064—Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides containing six-membered rings with nitrogen as a ring hetero atom containing condensed or non-condensed pyrimidines
    • A61K31/7076—Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides containing six-membered rings with nitrogen as a ring hetero atom containing condensed or non-condensed pyrimidines containing purines, e.g. adenosine, adenylic acid
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/14—Antivirals for RNA viruses
    • A61P31/18—Antivirals for RNA viruses for HIV

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Molecular Biology (AREA)
  • Virology (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • AIDS & HIV (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Genetics & Genomics (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Engineering & Computer Science (AREA)
  • Biochemistry (AREA)
  • Biotechnology (AREA)
  • Epidemiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Saccharide Compounds (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
MA053280A 2018-08-09 2019-08-08 Composés utiles dans la thérapie du vih MA53280A (fr)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US201862716494P 2018-08-09 2018-08-09

Publications (1)

Publication Number Publication Date
MA53280A true MA53280A (fr) 2021-11-17

Family

ID=68072882

Family Applications (1)

Application Number Title Priority Date Filing Date
MA053280A MA53280A (fr) 2018-08-09 2019-08-08 Composés utiles dans la thérapie du vih

Country Status (15)

Country Link
US (1) US20220117993A1 (fr)
EP (1) EP3833437A1 (fr)
JP (1) JP2021534112A (fr)
KR (1) KR20210044806A (fr)
CN (1) CN112789085A (fr)
AR (1) AR115936A1 (fr)
AU (1) AU2019317810A1 (fr)
BR (1) BR112021002169A2 (fr)
CA (1) CA3108635A1 (fr)
CL (1) CL2021000329A1 (fr)
IL (1) IL280660A (fr)
MA (1) MA53280A (fr)
MX (1) MX2021001612A (fr)
TW (1) TW202023650A (fr)
WO (1) WO2020031131A1 (fr)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA3125991A1 (fr) 2019-01-25 2020-07-30 Brown University Compositions et procedes pour traiter, prevenir ou inverser une inflammation et des troubles associes a l'age
EP4010349A1 (fr) * 2019-08-08 2022-06-15 GlaxoSmithKline Intellectual Property (No. 2) Limited Dérivés de 4'-éthynyle -2'-désoxyadénosine et leur utilisation en thérapie contre le vih
JP2023518433A (ja) 2020-03-20 2023-05-01 ギリアード サイエンシーズ， インコーポレイテッド ４’－ｃ－置換－２－ハロ－２’－デオキシアデノシンヌクレオシドのプロドラッグ並びにその製造法及び使用法
CN116710465A (zh) * 2021-01-25 2023-09-05 腾盛博药生物科技有限公司 腺苷衍生物和包含其的药物组合物

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB427857A (en) 1934-08-02 1935-05-01 Newsum Sons & Company Ltd H A new or improved system of construction for skeleton structures, particularly vehicle body frames and door frames
US4107288A (en) 1974-09-18 1978-08-15 Pharmaceutical Society Of Victoria Injectable compositions, nanoparticles useful therein, and process of manufacturing same
US5145684A (en) 1991-01-25 1992-09-08 Sterling Drug Inc. Surface modified drug nanoparticles
WO2002074769A1 (fr) 2001-03-19 2002-09-26 Ono Pharmaceutical Co., Ltd. Medicaments contenant comme principe actif des derives du triazaspiro [5.5] undecane
CA2502109C (fr) * 2004-03-24 2010-02-23 Yamasa Corporation Derive de 2-haloadenosine avec substitution sur le carbone en position 4'
CA2685748A1 (fr) * 2007-05-14 2008-11-14 Rfs Pharma, Llc. Nucleosides azidopuriques pour le traitement d'infections virales
WO2015143712A1 (fr) * 2014-03-28 2015-10-01 Merck Sharp & Dohme Corp. Inhibiteurs nucléosidiques substitués en 4' de la transcriptase inverse
EA035028B1 (ru) * 2015-08-10 2020-04-20 Мерк Шарп И Доум Корп. Противовирусные фосфодиамидные сложноэфирные бета-аминокислотные соединения
US20190185508A1 (en) * 2017-12-15 2019-06-20 Merck Sharp & Dohme Corp. Deuterated nucleoside reverse transcriptase inhibitors

Also Published As

Publication number Publication date
AU2019317810A1 (en) 2021-02-25
AR115936A1 (es) 2021-03-17
TW202023650A (zh) 2020-07-01
BR112021002169A2 (pt) 2021-05-04
MX2021001612A (es) 2021-05-13
IL280660A (en) 2021-03-25
CN112789085A (zh) 2021-05-11
KR20210044806A (ko) 2021-04-23
JP2021534112A (ja) 2021-12-09
CA3108635A1 (fr) 2020-02-13
WO2020031131A1 (fr) 2020-02-13
EP3833437A1 (fr) 2021-06-16
CL2021000329A1 (es) 2021-09-03
US20220117993A1 (en) 2022-04-21

Similar Documents

Publication Publication Date Title
DK3687994T3 (da) Gadolinium-bærende pcta-baserede kontrastmidler
DK3573877T3 (da) Løbeværk
MA55200A (fr) Composés utiles dans la thérapie du vih
MA53280A (fr) Composés utiles dans la thérapie du vih
UA38744S (uk) Монітор
DK3738452T3 (da) Fordamper
DK3706699T3 (da) Badekonstruktion
DK3620208T3 (da) Kanyle
DK3434403T3 (da) Arbejdsstation
DK3359102T3 (da) Medicinsk plaster
FI20155818A (fi) Järjestely työkoneen nivelliitoksessa
UA37893S (uk) Шпатель
UA37888S (uk) Шпатель
UA37886S (uk) Шпатель
DE112020000103A5 (de) Spannbacken
UA39056S (uk) Ванна
UA38944S (uk) Ванна
JP1737645S (ja) 引手
UA41578S (uk) Ложка столова
FI11901U1 (fi) Paistinlasta
ES1236409Y (es) Guante
ES1243687Y (es) Salmorejo
IT201900020430A1 (it) Espositore
DE202019004111U8 (de) Weichenstellvorichtung
TH190914S (th) ขันโตก